Interestingly, CYP4F12 mRNA expression was shown to be downregulated upon treatment with AR inhibitors enzalutamide or ARN‐509 in PCa‐derived cells [69], in line with the results observed in UM‐UC‐3‐AR. This evidence concerns the gene CYP4F12 and posterior cortical atrophy.